Invention Grant
- Patent Title: Reverse micelle system comprising nucleic acids and use thereof
- Patent Title (中): 包含核酸的反胶束体系及其用途
-
Application No.: US13636452Application Date: 2011-03-24
-
Publication No.: US08877237B2Publication Date: 2014-11-04
- Inventor: Jean-Claude Maurel
- Applicant: Jean-Claude Maurel
- Applicant Address: FR Baillargues
- Assignee: Medesis Pharma
- Current Assignee: Medesis Pharma
- Current Assignee Address: FR Baillargues
- Agency: Saliwanchik, Lloyd & Eisenschenk
- Priority: EP10305299 20100324
- International Application: PCT/EP2011/054512 WO 20110324
- International Announcement: WO2011/117334 WO 20110929
- Main IPC: A61K9/127
- IPC: A61K9/127 ; C12N15/11 ; A61K48/00
Abstract:
The present invention relates to reverse micelle system based on sterols, acylglycerols, phospholipids or sphingolipids and nucleic acids. The reverse micelle system of the invention is able to cross mucosa and cellular membranes. It thus allows vectorization of nucleic acids to target sites. It is advantageously useful in the pharmaceutical and dietetic fields.
Public/Granted literature
- US20130065944A1 REVERSE MICELLE SYSTEM COMPRISING NUCLEIC ACIDS AND USE THEREOF Public/Granted day:2013-03-14
Information query
